Insider trades
Dean Y. Li, Director of Recursion Pharmaceuticals RXRX, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $3M. The latest trade was on 06/17.
Dean Y. Li
Director
- First filing
- 23/01/05
- Trades
- 47 trades
- Buys / sales
- 0 / 5
- 12-month net buying
- −$3M
- Last trade
- 06/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
MerckMRK | Open-market sale | 02/10 | 02/10 | 10,235 sh | $117.52 | $1,202,817.2 | −10.0% |
MerckMRK | Open-market sale | 02/04 | 02/06 | 15,087 sh | $118.77 | $1,791,882.99 | −12.9% |
MerckMRK | Open-market sale | 24/02/09 | 24/02/12 | 14,702 sh | $125.50 | $1,845,101 | −24.1% |
RXRX | Open-market sale10b5-1 plan | 24/01/09 | 24/01/11 | 29,000 sh2 trades | $13.66avg. | $396,215.56 | −6.4% |
